You seem to be using an outdated version of Internet Explorer. Please note that this site does not support this browser version (a href="">as does Microsoft). You may experience design inconsistencies and error messages. We are sorry for any inconveniences.


People at High-Tech Gruenderfonds

Dr. Frank Hensel – Senior Investment Manager

Dr Frank Hensel is Investment Manager, scientist and founder of OncoMab GmbH, a spin-off of the University of Würzburg’s Institute of Pathology. The expert for tumour-reactive antibodies brings with him significant experience in biotechnology. His focus lies in the development of biologicals from the manufacturing phase to the clinical-trial stage.



+49 – 228 – 82300 – 142